what will be the price pop if the decision is positive?
Hi wee_wee, welcome to the board. It doesn't seem like you know too much about the actual events and the products. First, DVAX is very different from ALXA. Im not sure if you are truly trying to understand what DVAX is or just trying to sound intelligent while you bash, but it is awful comparison. Next, a lot of us who know about DVAX, followed them and listened to the Adcom know that there is actually a HIGH probability of approval next month. Im assuming that you did not listen to the Adcom questioning safety, so I will fill you in. Efficacy = GOOD. Safety = BAD, but because there was not a good enough racial profile for test subjects as they claimed. This felt like a larger point, which may have validity, but more for big PHARMA than DVAX. Why you may ask then did they take it out on DVAX? Well, because big PHARMA pays their salaries and they are struggling with having a moral compass and not biting the hand that feeds. None of this matters though as the FDA was present at the meeting and stated that the study was sufficient in their eyes in terms of subjects and far exceeded their expectations in terms of size.